Drug Type Small molecule drug |
Synonyms NUC 7738 |
Target |
Mechanism RNA inhibitors, RNA synthesis inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Molecular FormulaC26H29N6O7P |
InChIKeyUDLWWGQHMQIYCV-LKKHFEEPSA-N |
CAS Registry2348493-39-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced cancer | Phase 2 | GB | 17 Jun 2019 | |
Advanced Malignant Solid Neoplasm | Phase 2 | GB | 17 Jun 2019 | |
Lymphoma | Phase 2 | GB | 17 Jun 2019 |
Phase 1/2 | - | pgwxvocxnj(hubytqyzrn) = cognrjsyng gtppcuxmpi (docycschbs ) | - | 04 Apr 2023 | |||
Phase 1/2 | 17 | aktsxizwms(pdxzgyeikc) = 1350 mg/m2 Q1W wixosrxbyn (lrceyglpfb ) View more | Positive | 12 Sep 2022 |